Remember that automatic translation may not be accurate.
AbbVie was established in 2013, and is a well known Corporate Investor. The fund is located in United States, North America. The primary office of this Corporate Investor is located in Chicago.
The fund usually participates in less than 2 investment rounds per year. In real terms, this Corporate Investor performs 30 percentage points more exits than other funds. Deals in the range of 10 - 50 millions dollars are most common for this fund. This fund was the most active in 2016.
The fund usually invests in rounds together with 4-5 others. Besides AbbVie, start-ups are typically funded by Takeda Pharmaceutical, National Institutes of Health. Other VCs who often invest in the same rounds are Pfizer Venture Investments, Johnson & Johnson Innovation, Eli Lilly, the total number of co-investors is 3. The investors in the following rounds are usually National Institutes of Health, Alzheimer's Association.
Among the most popular investment industries for the fund are Biotechnology, Health Diagnostics. However, the fund’s focus is not limited to this, since there are 5 more areas of investment. Among the most popular portfolio start-up of the fund, is Lodo Therapeutics. The country of its foundation and the country of the most frequent investments for the fund coincides - United States.